Aspect Partners’s Veracyte VCYT Stock Holding History

Aspect Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-70	Closed	-$2.77K	–	657
2024 Q4	$2.77K	Buy	+70	New	+$2.65K	﹤0.01%	446

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Aspect Partners's VCYT Position: Q1 2025 in Review

Aspect Partners sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 70 shares — an estimated $2.77K sold.

Aspect Partners first reported a position in VCYT in Q4 2024 and held it in 1 quarter. The position peaked at $2.77K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

Aspect Partners reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
Aspect Partners sold 70 Veracyte shares in Q1 2025, an estimated $2.77K.
Aspect Partners first reported a position in Veracyte in Q4 2024 and held it in 1 quarter.
Aspect Partners's Veracyte position peaked at $2.77K in Q4 2024.
287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Aspect Partners's 13F filing for Q1 2025, filed 24 Apr 2025.